165 related articles for article (PubMed ID: 27194138)
21. Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component.
Yang DT; Dunphy CH; Tripp SR; Lagoo AS; Perkins SL
Am J Hematol; 2008 Mar; 83(3):218-21. PubMed ID: 17918256
[TBL] [Abstract][Full Text] [Related]
22. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).
Lo AC; Major A; Super L; Appel B; Shankar A; Constine LS; Marks LJ; Kelly KM; Metzger ML; Buhtoiarov IN; Mauz-Körholz C; Costa ARS; Binkley MS; Flerlage J
Leuk Lymphoma; 2022 Aug; 63(8):1997-2000. PubMed ID: 35357263
[No Abstract] [Full Text] [Related]
23. Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations.
Agaimy A; Wild V; Märkl B; Wachter DL; Hartmann A; Rosenwald A; Ihrler S
Am J Surg Pathol; 2015 Sep; 39(9):1206-12. PubMed ID: 25929348
[TBL] [Abstract][Full Text] [Related]
24. XVI. Early stage Hodgkin lymphoma.
Radford J
Hematol Oncol; 2015 Jun; 33 Suppl 1():84-6. PubMed ID: 26062062
[No Abstract] [Full Text] [Related]
25. "Popcorn cells" in intraoperative touch imprints of nodular lymphocyte-predominant Hodgkin lymphoma.
Aragao A; Kilic I; Velankar MM; Pambuccian SE
Diagn Cytopathol; 2020 Feb; 48(2):177-180. PubMed ID: 31793243
[No Abstract] [Full Text] [Related]
26. Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma.
Ding Y; Campbell A; Zhang X; Fu K; Yuan J
Pathology; 2021 Feb; 53(2):285-288. PubMed ID: 32951907
[No Abstract] [Full Text] [Related]
27. The importance of follow-up biopsies of clinically suspicious lymphadenopathy in nodular lymphocyte predominant Hodgkin's lymphoma.
Achten R; Verhoef G; De Wolf-Peeters C
Haematologica; 2003 Dec; 88(12):1431-2. PubMed ID: 14688002
[No Abstract] [Full Text] [Related]
28. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
[TBL] [Abstract][Full Text] [Related]
29. Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma.
Song JY; Egan C; Bouska AC; Zhang W; Gong Q; Venkataraman G; Herrera AF; Chen L; Ottesen R; Niland JC; Bedell V; Valle-Catuna M; Murata-Collins J; Weisenburger DD; Iqbal J; Jaffe ES; Chan WC
Leukemia; 2020 Aug; 34(8):2238-2242. PubMed ID: 32054999
[No Abstract] [Full Text] [Related]
30. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
31. Primary nodular lymphocyte predominant Hodgkin lymphoma of the palate: a rare incidence which was also associated with progressive transformation of germinal centres of cervical lymph node.
Ali H; Naresh K; Aqel NM
J Egypt Natl Canc Inst; 2013 Sep; 25(3):161-3. PubMed ID: 23932753
[TBL] [Abstract][Full Text] [Related]
32. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
33. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
34. Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung.
Gupta S; Cogbill CH; Gheorghe G; Rao AR; Kumar S; Havens PL; Camitta BM; Warwick AB
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e127-31. PubMed ID: 21399527
[TBL] [Abstract][Full Text] [Related]
35. "Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease.
Carbone A; Gloghini A
Hum Pathol; 2012 May; 43(5):619-28. PubMed ID: 22209342
[TBL] [Abstract][Full Text] [Related]
36. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic strategies of Hodgkin's disease].
Lathan B; Pfreundschuh M; Diehl V
Internist (Berl); 1993 Feb; 34(2):146-54. PubMed ID: 8454428
[No Abstract] [Full Text] [Related]
38. Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin's lymphoma.
Vassilakopoulos TP; Angelopoulou MK; Pangalis GA
Leuk Lymphoma; 2006 Aug; 47(8):1450-1. PubMed ID: 16966251
[No Abstract] [Full Text] [Related]
39. Rituximab monotherapy in nodular lymphocyte-predominant Hodgkin's disease.
Boulanger E; Meignin V; Leverger G; Solal-Céligny P
Ann Oncol; 2003 Jan; 14(1):171. PubMed ID: 12488312
[No Abstract] [Full Text] [Related]
40. A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease.
Borg-Grech A; Radford JA; Crowther D; Swindell R; Harris M
J Clin Oncol; 1989 Sep; 7(9):1303-9. PubMed ID: 2769329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
